(Q42356161)

28 October 2017

Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey (English)

1 reference

28 October 2017

1 reference

Maryse Lapeyre-Mestre

object named as

Maryse Lapeyre-Mestre

10

0 references

Jean-Louis Montastruc

9

object named as

Jean-Louis Montastruc

1 reference

28 October 2017

5

Lionel Rostaing

1 reference

28 October 2017

Laurent Sailler

1

1 reference

28 October 2017

Camille Attane

2

1 reference

28 October 2017

Fleur Michenot

3

1 reference

28 October 2017

Jean-Marie Canonge

4

1 reference

28 October 2017

Elizabeth Arlet-Suau

6

1 reference

28 October 2017

Philippe Arlet

7

1 reference

28 October 2017

François Launay

8

1 reference

28 October 2017

language of work or name

English

0 references

publication date

10 April 2008

1 reference

British Journal of Clinical Pharmacology

28 October 2017

1 reference

28 October 2017

66

1 reference

28 October 2017

2

1 reference

28 October 2017

320-322

1 reference

Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments

28 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492921

Immune status and risk for infection in patients receiving chronic immunosuppressive therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492921

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492921

Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492921

Adverse drug reactions: definitions, diagnosis, and management

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492921

B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492921

Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492921

10.1111/J.1365-2125.2008.03193.X

1 December 2018

Identifiers

DOI

1 reference

28 October 2017

1 reference

28 October 2017

PubMed publication ID

18485050

1 reference